Marvell’s $115 Billion Lumentum Bet Faces a Valuation Test

Marvell’s shares fell from about $264 to $141.20 in five weeks. A $115 billion Lumentum deal adds optics and $1 billion in annual savings, but dilution and cyclicality complicate the thesis.